Teva Pharmaceutical Industries (TEVA) EBITDA (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) posted EBITDA of $10 million for Q2 2026, down 98.6% from $706 million a year earlier and down 98.9% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EBITDA (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Teva Pharmaceutical Industries was $2.59 billion, up 35.2% year-over-year; for FY2025, it was $3.16 billion, up 317.9% from FY2024.
- In prior years, Teva Pharmaceutical Industries' EBITDA was $756 million in FY2024 (-52.3%), $1.59 billion in FY2023, -$889 million in FY2022 and $3.05 billion in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBITDA since Q2 2023.
- On a year-over-year basis, EBITDA increased in four of the last seven quarters, with growth averaging 75.7%.
- The strongest year-over-year quarter for EBITDA in the past five years was Q3 2025, with growth of 443.8%; the weakest was Q2 2026, with a decline of 98.6%.
- According to Business Quant data, EBITDA for the three prior quarters was $891 million (Q1 2026), $560 million (Q4 2025) and $1.13 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Teva Pharmaceutical Industries | 48.14 Bn | 34.98 Bn | 2.15 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.00 Mn |
| Mar 31, 2026 | 891.00 Mn |
| Dec 31, 2025 | 560.00 Mn |
| Sep 30, 2025 | 1.13 Bn |
| Jun 30, 2025 | 706.00 Mn |
| Mar 31, 2025 | 763.00 Mn |
| Dec 31, 2024 | 240.00 Mn |
| Sep 30, 2024 | 208.00 Mn |
| Jun 30, 2024 | 254.00 Mn |
| Mar 31, 2024 | 54.00 Mn |
| Dec 31, 2023 | 1.02 Bn |
| Sep 30, 2023 | 627.00 Mn |
| Jun 30, 2023 | -354.00 Mn |
| Mar 31, 2023 | 291.00 Mn |
| Dec 31, 2022 | -634.00 Mn |
| Sep 30, 2022 | 745.00 Mn |
| Jun 30, 2022 | -609.00 Mn |
| Mar 31, 2022 | -390.00 Mn |
| Dec 31, 2021 | 398.00 Mn |
| Sep 30, 2021 | 952.00 Mn |
API Access
Teva Pharmaceutical Industries EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();